Research Article

Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom

Volume: 30 Number: 2 March 15, 2026

Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom

Abstract

Skin inflammation is a serious problem that must be addressed. The use of steroid and non-steroid drugs is effective as an anti-inflammatory but has many side effects. One of the natural ingredients used by the community as an anti-inflammatory is the leaves of the velvet bean (Mucuna pruriens L. (DC.)). This study aims to prove that velvet bean leaf ointment is effective as an anti-inflammatory, which is indicated by improvements in the morphology and structure of the skin tissue of mice experiencing inflammation. The research method is an experiment with a completely randomized design consisting of 6 treatments with five replications (normal, negative control, positive control, and velvet bean leaf ointment at 200, 400, and 600 mg/kgBW). Quantitative data were analyzed using Duncan's Multiple Range Test. The results showed that the use of ointments of 200 and 400 mg/kgBW was able to improve the morphology of the skin of mice experiencing inflammation, which was indicated by a significant decrease in the thickness of the back folds (P <0.05) and had the highest anti-inflammatory power of 35.77%. In addition, 200 mg/kg BW ointment improved the histological structure of the inflamed mouse skin tissue because it significantly reduced the dermis layer's thickness and the number of inflammatory cells in the dermis layer (P<0.05). Therefore, the velvet bean leaf ointment has great potential to be developed into a standardized anti-inflammatory drug because it effectively improves the morphology and histological structure of the inflamed mouse skin tissue.

Keywords

Supporting Institution

Thank you to Universitas Negeri Padang and Universitas Andalas for facilitating the implementation of this research.

Project Number

Contract No. 086/E5/PG.02.00.PT/2022; PIC Dr. Putra Santoso

Ethical Statement

All procedures and treatments of test animals were carried out based on the approval of the Andalas University Research Ethics Committee (No.612/UN.16.2/KEP-FK/2022).

Thanks

Thank you to the Ministry of Education, Culture, Research, and Technology for the funds provided for research through the National Competitive Program, namely the Postgraduate Research Scheme Master Thesis Research

References

  1. [1] Meizlish ML, Franklin RA, Zhou X, Medzhitov R. Tissue homeostasis and inflammation. Annual review of immunology. 2021;39(1):557-81. April 2021). https://doi.org/10.1146/annurev-immunol-061020-053734
  2. [2] Zanoli L, Briet M, Empana JP, Cunha PG, Mäki-Petäjä KM, Protogerou AD, Tedgui A, Touyz RM, Schiffrin EL, Spronck B, Bouchard P. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. Journal of hypertension. 2020;38(9):1682-98. https://doi.org/10.1097/HJH.0000000000002508
  3. [3] Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, Emdin M, Giannoni A. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. European journal of preventive cardiology. 2020;27(5):494-510. https://doi.org/10.1177/2047487319870344
  4. [4] Paglia MD, Silva MT, Lopes LC, Barberato-Filho S, Mazzei LG, Abe FC, de Cássia Bergamaschi C. Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis. PLoS One. 2021;16(4):e0248866. https://doi.org/10.1371/journal.pone.0248866
  5. [5] Tai FW, McAlindon ME. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clinical Medicine. 2021;21(2):131-4. https://doi.org/10.1371/journal.pone.0248866
  6. [6] Kholmurodovich UF. Damage to the digestive system when using non-steroidal anti-inflammatory drugs. European journal of modern medicine and practice. 2022;2(1):6-16.
  7. [7] Klomjit N, Ungprasert P. Acute kidney injury associated with non-steroidal anti-inflammatory drugs. European journal of internal medicine. 2022;101:21-8. https://doi.org/10.1016/j.ejim.2022.05.003
  8. [8] Bala, V., Debnath, A., Shill, A.K., and Bose, U. Anti-Inflammatory, Diuretic, and Antibacterial Activities of Aerial Parts of Mucuna pruriens Linn. International Journal of Pharmacy. 2011;7(4):498-503. https://doi.org/10.3923/ijp.2011.498.503

Details

Primary Language

English

Subjects

Pharmaceutical Sciences, Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Research Article

Publication Date

March 15, 2026

Submission Date

April 16, 2025

Acceptance Date

September 16, 2025

Published in Issue

Year 2026 Volume: 30 Number: 2

APA
Fadilaturahmah, F., Rahayu, R., & Santoso, P. (2026). Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom. Journal of Research in Pharmacy, 30(2), 553-568. https://doi.org/10.12991/jrespharm.1677318
AMA
1.Fadilaturahmah F, Rahayu R, Santoso P. Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom. J. Res. Pharm. 2026;30(2):553-568. doi:10.12991/jrespharm.1677318
Chicago
Fadilaturahmah, Fadilaturahmah, Resti Rahayu, and Putra Santoso. 2026. “Velvet Bean (Mucuna Pruriens L. (DC.)) Leaf Ointment: Candidate for Standardized Natural Anti-Inflammatory Drug Ingredients Based on Local Wisdom”. Journal of Research in Pharmacy 30 (2): 553-68. https://doi.org/10.12991/jrespharm.1677318.
EndNote
Fadilaturahmah F, Rahayu R, Santoso P (March 1, 2026) Velvet bean (Mucuna pruriens L. (DC.) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom. Journal of Research in Pharmacy 30 2 553–568.
IEEE
[1]F. Fadilaturahmah, R. Rahayu, and P. Santoso, “Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom”, J. Res. Pharm., vol. 30, no. 2, pp. 553–568, Mar. 2026, doi: 10.12991/jrespharm.1677318.
ISNAD
Fadilaturahmah, Fadilaturahmah - Rahayu, Resti - Santoso, Putra. “Velvet Bean (Mucuna Pruriens L. (DC.)) Leaf Ointment: Candidate for Standardized Natural Anti-Inflammatory Drug Ingredients Based on Local Wisdom”. Journal of Research in Pharmacy 30/2 (March 1, 2026): 553-568. https://doi.org/10.12991/jrespharm.1677318.
JAMA
1.Fadilaturahmah F, Rahayu R, Santoso P. Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom. J. Res. Pharm. 2026;30:553–568.
MLA
Fadilaturahmah, Fadilaturahmah, et al. “Velvet Bean (Mucuna Pruriens L. (DC.)) Leaf Ointment: Candidate for Standardized Natural Anti-Inflammatory Drug Ingredients Based on Local Wisdom”. Journal of Research in Pharmacy, vol. 30, no. 2, Mar. 2026, pp. 553-68, doi:10.12991/jrespharm.1677318.
Vancouver
1.Fadilaturahmah Fadilaturahmah, Resti Rahayu, Putra Santoso. Velvet bean (Mucuna pruriens L. (DC.)) leaf ointment: candidate for standardized natural anti-inflammatory drug ingredients based on local wisdom. J. Res. Pharm. 2026 Mar. 1;30(2):553-68. doi:10.12991/jrespharm.1677318